Bridget M Kuehn. Show Affiliations »
Abstract
Mesh： See more » Aminobutyrates/adverse effectsAminobutyrates/economicsAminobutyrates/therapeutic useAnimalsCardiovascular Agents/adverse effectsCardiovascular Agents/economicsCardiovascular Agents/therapeutic useCost-Benefit AnalysisDrug CombinationsDrug Costs/trendsDrug Discovery/economicsDrug Discovery/trendsDrug Industry/economicsDrug Industry/trendsHealth Services Accessibility/economicsHealthcare Disparities/economicsHumansPractice Patterns, Physicians'/economicsPractice Patterns, Physicians'/trendsRisk AssessmentTetrazoles/adverse effectsTetrazoles/economicsTetrazoles/therapeutic use
Substances： See more » AminobutyratesCardiovascular AgentsDrug CombinationsTetrazolessacubitril and valsartan sodium hydrate drug combination
Year: 2018 PMID： 29311350 DOI： 10.1161/CIRCULATIONAHA.117.032982
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690